C

Can Fite Biopharma Ltd
TASE:CANF

Watchlist Manager
Can Fite Biopharma Ltd
TASE:CANF
Watchlist
Price: 1 ILS Market Closed
Market Cap: 78.6m ILS

Wall Street
Price Targets

CANF Price Targets Summary
Can Fite Biopharma Ltd

There are no price targets for CANF.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Can Fite Biopharma Ltd Competitors:
Price Targets
ARX
Aroa Biosurgery Ltd
29% Upside
ARQT
Arcutis Biotherapeutics Inc
11% Upside
FOLD
Amicus Therapeutics Inc
59% Upside
688180
Shanghai Junshi Biosciences Co Ltd
28% Downside
KURA
Kura Oncology Inc
229% Upside
SOBI
Swedish Orphan Biovitrum AB (publ)
10% Upside
005690
Pharmicell Co Ltd
3% Upside

Revenue
Forecast

Revenue Estimate
Can Fite Biopharma Ltd

For the last 13 years the compound annual growth rate for Can Fite Biopharma Ltd's revenue is 2%. The projected CAGR for the next 3 years is 140%.

2%
Past Growth
140%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Can Fite Biopharma Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-74%
Average Miss

Net Income
Forecast

Net Income Estimate
Can Fite Biopharma Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-84%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CANF's stock price target?
Not Available

CANF doesn't have any price targets made by Wall Street professionals.

What is Can Fite Biopharma Ltd's Revenue forecast?
Projected CAGR
140%

For the last 13 years the compound annual growth rate for Can Fite Biopharma Ltd's revenue is 2%. The projected CAGR for the next 3 years is 140%.

Back to Top